Q&M to invest S$3m to build Covid-19 testing business
Add BT as a preferred sourceDeeperDive is a beta AI feature. Refer to full articles for the facts.
Singapore
Q&M Dental Group is investing S$3 million to build a new Covid-19 testing business via a joint venture that includes local scientist Ong Siew Hwa, the company said on Thursday.
Dr Ong is the founder of Acumen Research Laboratories (ARL), a local biotech company developing rapid, polymerase chain reaction (PCR)-based, culture-independent molecular diagnostic tests, with a focus on infectious diseases.
Decoding Asia newsletter: your guide to navigating Asia in a new global order. Sign up here to get Decoding Asia newsletter. Delivered to your inbox. Free.
Copyright SPH Media. All rights reserved.
TRENDING NOW
Air India asks Tata, Singapore Airlines for funds after US$2.4 billion loss
‘Boring’ is the new black: The stars are aligning for a Singapore stock market revival
From 1MDB to ‘corporate mafia’: Is Malaysia facing a new governance test?
South-east Asian markets account for 8.8% of global capital inflows from 2021 to 2024: report
